Related Experiment Video
Updated: Jan 13, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis
Shuai Xia1, Zhiying He1, Xiaoning Wu1
1Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, State Key Lab of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing, China.
Recompensation status in hepatitis B virus (HBV)-related decompensated cirrhosis varies. Patients with unstable recompensation face poorer survival than stable recompensation, highlighting the need for distinct classifications.
Area of Science:
- Hepatology
- Viral Hepatitis
- Cirrhosis Research
Background:
- Hepatitis B virus (HBV)-related decompensated cirrhosis patients achieving recompensation can still experience further decompensation.
- Recompensation status is dynamic and requires further classification.
Purpose of the Study:
- To classify patterns of recompensation in HBV-related decompensated cirrhosis.
- To characterize clinical differences among recompensation subgroups.
Main Methods:
- Patients with HBV-related decompensated cirrhosis were followed for up to 5 years.
- Recompensation was defined by Baveno VII criteria and categorized as stable or unstable.
- Clinical characteristics and complications were assessed every 6 months.
Main Results:
- Of 378 patients, 294 (77.8%) achieved recompensation.
- Stable recompensation occurred in 53.4% and unstable in 24.3%.
- Unstable recompensation showed higher 5-year rates of hepatocellular carcinoma (HCC) or mortality (14.7%) compared to stable recompensation (10.1%).
Conclusions:
- Recompensation is not uniform and requires subclassification into stable and unstable states.
- Unstable recompensation is associated with poorer survival than stable recompensation.
- Outcomes for unstable recompensation remain better than for ongoing decompensation.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Compensation Mechanisms
Respiratory Compensation
This mechanism addresses metabolic-induced pH imbalances by adjusting breathing rates. Respiratory compensation begins within minutes of detecting a pH...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

